[1]
Agus Setyawan, U. et al. 2025. Progression Free Survival in Lung Cancer Adenocarcinoma Wild Type Patients with Pemetrexed Regimen Combination of Cisplatin compared to Carboplatin. Jurnal Klinik dan Riset Kesehatan. 4, 2 (Feb. 2025), 87–94. DOI:https://doi.org/10.11594/jk-risk.04.2.2.